Cargando…
Targeting hepatic glutaminase activity to ameliorate hyperglycemia
Autores principales: | Miller, Russell A., Shi, Yuji, Lu, Wenyun, Pirman, David A., Jatkar, Aditi, Blatnik, Matthew, Wu, Hong, Cárdenas, César, Wan, Min, Foskett, J. Kevin, Park, Junyoung O., Zhang, Yiyi, Holland, William L, Rabinowitz, Joshua D., Birnbaum, Morris J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089616/ https://www.ncbi.nlm.nih.gov/pubmed/29578539 http://dx.doi.org/10.1038/nm.4514 |
Ejemplares similares
-
Spontaneous colitis in IL‐10‐deficient mice was ameliorated via inhibiting glutaminase1
por: Li, Jing, et al.
Publicado: (2019) -
The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy
por: Lukey, Michael J., et al.
Publicado: (2016) -
Targeting glutaminase and mTOR
por: Tanaka, Kazuhiro, et al.
Publicado: (2015) -
Upregulation of the Glutaminase II Pathway Contributes to Glutamate Production upon Glutaminase 1 Inhibition in Pancreatic Cancer
por: Udupa, Sunag, et al.
Publicado: (2019) -
Dendrimer-conjugated glutaminase inhibitor selectively targets microglial glutaminase in a mouse model of Rett syndrome
por: Khoury, Elizabeth Smith, et al.
Publicado: (2020)